Blood Res.  2014 Jun;49(2):75-76. 10.5045/br.2014.49.2.75.

How old is old: the beginning of a new era for therapeutic challenges for elderly patients with AML

• Kim HJ

• KMID: 2172798
• DOI: http://doi.org/10.5045/br.2014.49.2.75

Abstract

No abstract available.

MeSH Terms

Aged*
Humans

Reference

1. National Cancer Institute. The SEER Program. Bethesda, MD: National Institutes of Health;2012. Accessed June 17, 2014. at http://seer.cancer.gov/about/.

2. Oran B, Weisdorf DJ. Survival for older patients with acute myeloid leukemia: a population-based study. Haematologica. 2012; 97:1916–1924. PMID: 22773600.

3. Ustun C, Lazarus HM, Weisdorf D. To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century. Bone Marrow Transplant. 2013; 48:1497–1505. PMID: 23645167.

4. Juliusson G. Older patients with acute myeloid leukemia benefit from intensive chemotherapy: an update from the Swedish Acute Leukemia Registry. Clin Lymphoma Myeloma Leuk. 2011; 11(Suppl 1):S54–S59. PMID: 22035749.

5. Oshima K, Takahashi W, Asano-Mori Y, et al. Intensive chemotherapy for elderly patients with acute myelogeneous leukemia: a propensity score analysis by the Japan Hematology and Oncology Clinical Study Group (J-HOCS). Ann Hematol. 2012; 91:1533–1539. PMID: 22576311.

6. Baz R, Rodriguez C, Fu AZ, et al. Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia. Cancer. 2007; 110:1752–1759. PMID: 17724726.

7. Yi HG, Lee MH, Kim CS, et al. Clinical characteristics and treatment outcome of acute myeloid leukemia in elderly patients in Korea: a retrospective analysis. Blood Res. 2014; 49:95–99.

8. Al-Ali HK, Jaekel N, Niederwieser D. The role of hypomethylating agents in the treatment of elderly patients with AML. J Geriatr Oncol. 2014; 5:89–105. PMID: 24484723.

9. Eom KS, Kim HJ, Cho BS, et al. Hematopoietic stem cell transplant following remission induction chemotherapy including gemtuzumab ozogamicin is a feasible and effective treatment option in elderly patients with acute myeloid leukemia. Leuk Lymphoma. 2011; 52:2321–2328. PMID: 22023488.

10. Yoon JH, Cho BS, Kim HJ, et al. Outcomes of elderly de novo acute myeloid leukemia treated by a risk-adapted approach based on age, comorbidity, and performance status. Am J Hematol. 2013; 88:1074–1081. PMID: 23983148.